Sangamo Therapeutics
SGMO
#8725
Rank
ยฃ0.12 B
Marketcap
ยฃ0.37
Share price
-6.45%
Change (1 day)
-76.41%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: ยฃ0.12 Billion

As of December 2025 Sangamo Therapeutics has a market cap of ยฃ0.12 Billion. This makes Sangamo Therapeutics the world's 8725th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ0.12 B-70.59%
2024ยฃ0.42 B462.79%
2023ยฃ75.62 M-82.22%
2022ยฃ0.42 B-47.45%
2021ยฃ0.80 B-50.01%
2020ยฃ1.61 B118.75%
2019ยฃ0.74 B-19.9%
2018ยฃ0.92 B-9.89%
2017ยฃ1.02 B487.52%
2016ยฃ0.17 B-59.73%
2015ยฃ0.43 B-35.76%
2014ยฃ0.67 B28.73%
2013ยฃ0.52 B165.66%
2012ยฃ0.19 B105.78%
2011ยฃ95.87 M-50.88%
2010ยฃ0.19 B18.58%
2009ยฃ0.16 B69.17%
2008ยฃ97.3 M-63.18%
2007ยฃ0.26 B123.77%
2006ยฃ0.11 B65.28%
2005ยฃ71.44 M-9.54%
2004ยฃ78.98 M3.5%
2003ยฃ76.3 M64.3%
2002ยฃ46.44 M-70.55%
2001ยฃ0.15 B-45.5%
2000ยฃ0.28 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Sangamo Therapeutics was reported to be:

ยฃ0.12 Billion
by Nasdaq info icon info icon
ยฃ0.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
ยฃ112.81 B 90,037.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ45.39 B 36,170.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ133.24 B 106,355.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ19.94 B 15,839.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
ยฃ12.24 B 9,679.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ364.92 B 291,453.85%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ7.69 B 6,047.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ186.82 B 149,167.40%๐Ÿ‡บ๐Ÿ‡ธ USA